G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 369,290 | 103,812 | 47,305 | N/A | N/A |
| TOTAL | $370,133 | $104,661 | $47,901 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,137 | 510 | 311 | N/A | N/A |
| TOTAL | $1,137 | $510 | $311 | $N/A | $N/A |
| Total Assets | $371,270 | $105,171 | $48,212 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 167 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,377 | 4,184 | 2,605 | 0 | 0 |
| Accrued Expenses | 8,985 | 7,520 | 2,853 | N/A | N/A |
| TOTAL | $12,362 | $11,704 | $5,625 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 88 | 79 | 0 | 0 | 0 |
| TOTAL | $88 | $79 | $N/A | $N/A | $N/A |
| Total Liabilities | $12,450 | $11,783 | $5,625 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,408 | 28,445 | N/A | N/A | N/A |
| Common Shares | 4 | 3 | N/A | N/A | N/A |
| Retained earnings | -214,406 | -129,118 | -64,985 | N/A | N/A |
| Other shareholders' equity | -8 | -8 | 107,572 | 0 | 0 |
| TOTAL | $358,820 | $93,388 | $42,587 | $N/A | $N/A |
| Total Liabilities And Equity | $371,270 | $105,171 | $48,212 | $0 | $0 |